Search Close Search

UMass Cancer Center

Our mission is to advance the cancer control continuum—from etiology through survivorship—in patients of all ages and with all types of cancer, through cutting-edge research, excellence in education, community-based outreach and the delivery of compassionate, patient-centered care.

 

 cancer-center-find-clinical-trials.png

Find Clinical Trials

The largest selection of advanced clinical trials in Central Massachusetts

 cancer-center-our-clinicians.png

Meet Our Clinicians

World-class patient care, offering the latest advances in personalized treatment approaches

 Lab Image

Explore Cancer Research

Breakthroughs in research helping serve communities all around the world

 cancer-center-ways-to-give.png

Ways to Give

There are many ways to show your support for groundbreaking cancer research and clinical trials that will lead to newer, better methods for the prevention, detection, diagnosis and treatment of cancer.

smith-jordan-xue-wen-660.png

Research Programs

UMass Cancer Center is a powerhouse in cancer research. Our scientists and clinical researchers have been recruited from around the world and are leaders in their field who work to advance our understanding of cancer initiation, progression, treatment and prevention through groundbreaking basic, translational, clinical and population research.

 

Learn more

heart-regular.svg

Help Us Make A Difference

Your help will make a enormous difference

 

WAYS TO GIVE

 

Page Menu

UMass Cancer Center News

Getting Results…
  • In new study, UMass Chan scientists induce toxicity to kill cancer cells

    In new study, UMass Chan scientists induce toxicity to kill cancer cells

    Dohoon Kim, PhD, and colleagues have shown that blocking a specific detoxifying enzyme in lung cancer cells leads to cell death, making it a viable target for drug development.

    Read more
  • Study co-authored by Jonathan Gerber shows COVID-19 vaccines reduce harmful inflammation

    Study co-authored by Jonathan Gerber shows COVID-19 vaccines reduce harmful inflammation

    Vaccination against COVID-19 was linked to reduced inflammation in response to SARS-CoV-2 infection, according to a paper co-authored by UMass Chan Medical School researcher Jonathan M. Gerber, MD.

    Read more
  • Marcus Ruscetti receives American Cancer Society award for prostate cancer research

    Marcus Ruscetti receives American Cancer Society award for prostate cancer research

    The Research Scholar Grant will support Dr. Ruscetti’s research on senescent cells and their role in tumor progression and immune suppression in prostate cancer.

    Read more
  • Phillip Zamore, Roger Davis elected to National Academy of Medicine

    Phillip Zamore, Roger Davis elected to National Academy of Medicine

    UMass Chan Medical School scientists Phillip D. Zamore, PhD, and Roger J. Davis, PhD, FRS, were elected to the National Academy of Medicine on Oct. 9 for their distinguished contributions to medicine and health.

    Read more
  • Scientific symposium celebrates Michael Green’s lasting legacy

    Scientific symposium celebrates Michael Green’s lasting legacy

    More than a dozen of Michael Green’s former colleagues, trainees and others are scheduled to speak at the symposium.

    Read more
  • Six new endowed chairs named at UMass Chan Medical School

    Six new endowed chairs named at UMass Chan Medical School

    These highly accomplished faculty members have been appointed to endowed chairs at UMass Chan Medical School: Dale L. Greiner, PhD; Danny G. Winder, PhD; Elinor K. Karlsson, PhD; Jeannette M. Wolfe, MD; J. Kevin Donahue, MD; and John E. Harris, MD, PhD’05.

    Read more